Hikma Opioid Settlement: Is It A Scam? What You Must Know
Did you receive the Hikma Opioid Settlement e-mail? It’s not a scam.
Hikma Pharmaceuticals is paying out $150 million to settle claims tied to the opioid crisis. Apparently, some states and localities accused them of not reporting sketchy opioid orders from shady distributors.
Who Is Eligible Hikma Opioid Settlement
Hikma Pharmaceuticals is handing over $150 million to settle claims that it played a role in making the opioid crisis worse. You see, some states and localities were on their case, saying they didn’t report shady opioid orders from questionable distributors.
How Much Settlement
As part of the deal, Hikma will pay up $115 million in cash and either $35 million worth of opioid addiction treatment meds or straight-up cash. And that’s that, according to the Office of the New York State Attorney General.
Conclusion
is In re: National Prescription Opiate Litigation, Case No. 1:17-md-02804 Is not a scam. Just like Auto-Owners Mutual Insurance Co. Settlement According to New York Attorney General Letitia James, this settlement won’t magically fix everything that opioids have messed up.
